Prediabetes: prediction and prevention trialsVENDRAME, Francesco; GOTTLIEB, Peter A.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, ix, 75-92 [19 p.]Article

Type I DiabetesGOTTLIEB, Peter A.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, 270 p.Serial Issue

Environmental causes: viral causesHYÖTY, Heikki.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, viii, 27-44 [19 p.]Article

Genetics of type 1 diabetesPUGLIESE, Alberto.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, vii, 1-16 [17 p.]Article

Environmental causes: dietary causesVAARALA, Outi.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, vii, 17-26 [11 p.]Article

Autoimmune polyendocrine syndromesEISENBARTH, George S; GOTTLIEB, Peter A.The New England journal of medicine. 2004, Vol 350, Num 20, pp 2068-2079, issn 0028-4793, 12 p.Article

Engineering islets: lessons from stem cells and embryonic developmentDOYLE, Michelle J; SUSSEL, Lori.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, x, 149-162 [15 p.]Article

Microvascular complications of diabetesZHIHENG HE; KING, George L.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, pp xi-xii, issn 0889-8529, 26 p.Article

Treatment of type 1 diabetes mellitus to preserve insulin secretionHEROLD, Kevan C.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, ix, 93-111 [20 p.]Article

Becaplermin and necrobiosis lipoidicum diabeticorum : results of a case control pilot studySTEPHENS, Elizabeth; ROBINSON, Julie A; GOTTLIEB, Peter A et al.Journal of diabetes and its complications. 2001, Vol 15, Num 1, pp 55-56, issn 1056-8727Conference Paper

Insulin-specific tolerance in diabetesGOTTLIEB, Peter A; EISENBARTH, George S.Clinical immunology (Orlando, Fla. Print). 2002, Vol 102, Num 1, pp 2-11, issn 1521-6616Article

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of TreatmentORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Diabetes care. 2014, Vol 37, Num 4, pp 1069-1075, issn 0149-5992, 7 p.Article

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialWHERRETT, Diane K; BUNDY, Brian; MONZAVI, Roshanak et al.Lancet (British edition). 2011, Vol 378, Num 9788, pp 319-327, issn 0140-6736, 9 p.Article

Emerging therapies: Controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regenerationRUGGLES, James A; KELEMEN, Donald; BARON, Alain et al.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, xii, 239-252 [15 p.]Article

Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 DiabetesYOUNG, Kendra A; SNELL-BERGEON, Janet K; NAIK, Ramachandra G et al.Diabetes care. 2011, Vol 34, Num 2, pp 454-458, issn 0149-5992, 5 p.Article

Continuous Home Monitoring of Glucose : Improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetesGARG, Satish K; KELLY, William C; VOELMLE, Mary K et al.Diabetes care. 2007, Vol 30, Num 12, pp 3023-3025, issn 0149-5992, 3 p.Article

Autoreactive T cells in human type 1 diabetesTREE, Timothy I. M; PEAKMAN, Mark.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, pp ix-x, issn 0889-8529, 23 p.Article

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptideALLEVA, David G; GAUR, Amitabh; LING, Nicholas et al.Diabetes (New York, NY). 2002, Vol 51, Num 7, pp 2126-2134, issn 0012-1797Article

Disease prevention with islet autoantigensEISENBARTH, George S; JASINSKI, Jean M.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, viii, 59-73 [16 p.]Article

CD4⁺CD25^high regulatory T cells in human autoimmune diabetesPUTNAM, Amy L; VENDRAME, Francesco; DOTTA, Francesco et al.Journal of autoimmunity (Print). 2005, Vol 24, Num 1, pp 55-62, issn 0896-8411, 8 p.Article

β-Cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approachSUTHERLAND, David E. R; GRUESSNER, Angelika; HERING, Bernhard J et al.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, x, 135-148 [15 p.]Article

Glucose sensors: toward closed loop insulin deliveryCHIA, Chee W; SAUDEK, Christopher D.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 1, issn 0889-8529, xi, 175-195 [22 p.]Article

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsPESCOVITZ, Mark D; GREENBAUM, Carla J; RODRIGUEZ, Henry et al.Diabetes care. 2014, Vol 37, Num 2, pp 453-459, issn 0149-5992, 7 p.Article

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of RespondersHEROLD, Kevan C; GITELMAN, Stephen E; SAYRE, Peter H et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3766-3774, issn 0012-1797, 9 p.Article

Dominant Suppression of Addison's Disease Associated with HLA-B15BAKER, Peter R; BASCHAL, Erin E; BARKER, Jennifer M et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 7, pp 2154-2162, issn 0021-972X, 9 p.Article